The Diagnostics Industry Post-Covid: A Revival or Return to Baseline?

Published in MedTech Strategist

Authors: Wendy Diller, Oded Ben-Joseph, Craig Steger, and Thomas Joyce

Abstract:

The COVID-19 crisis shifted unprecedented resources to the diagnostics industry and presented a substantial growth opportunity for test manufacturers. A multitude of companies and entrepreneurs quickly pivoted toward developing innovative COVID tests, but whether they can survive post-pandemic exceptionalism remains to be seen.

View full article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    99 High St. Suite 2900, Boston, MA 02110
    (617) 431-4886